Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review
- PMID: 32507930
- DOI: 10.1007/s10143-020-01327-x
Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review
Abstract
An embryological association between moyamoya disease (MMD) and cardiac manifestations has been proposed. Data up to this point remains anecdotal, and the prevalence of cardiac manifestations in a western MMD population is uncertain. The objective of this study was to determine the prevalence of cardiac manifestations including coronary artery disease (CAD) and congenital cardiac defects in a mostly Caucasian population of MMD patients and review prior reports of such cases. Medical records of MMD patients who presented to our institution between 1990 and 2019 were retrospectively reviewed for the presence of various congenital cardiac malformations and concomitant CAD. The prevalence of congenital cardiac defects and CAD was determined. A literature search for prior cases of MMD with concomitant cardiac manifestations was performed. A total of 181 MMD patients were included in our analysis, 139 (76.8%) of whom were Caucasian. Ten patients had cardiac manifestations (5.5%). There were six total MMD patients with congenital cardiac defects (3.3%). All patients with congenital defects were diagnosed in childhood. The prevalence of congenital defects in MMD was slightly higher than the general population as reported previously (0.8-1.2%). Four MMD patients had CAD (2.2%). The mean age of patients with CAD was 41.0 years (SD = 12.3, range = 33-59) in our series and 33.1 years (SD = 15.0) in a review of prior reports. These mean ages of CAD are in contrast to the 7th and 8th decades of lifein the general population as indicated by prior studies. Our findings support an association between MMD and cardiac manifestations. Further investigation is warranted in order to further characterize this potential relationship and shed light on a possible cardio-cephalic neural crest syndrome.
Keywords: Cardiac; Cardiocephalic; Congenital cardiac defect; Coronary arterry disease; Moyamoya.
Similar articles
-
Cephalic/cardiac neural crest cell and moyamoya disease.Neuroradiol J. 2021 Dec;34(6):529-533. doi: 10.1177/19714009211021780. Epub 2021 Jun 2. Neuroradiol J. 2021. PMID: 34078151 Free PMC article. Review.
-
Incidence, prevalence, and treatment of Moyamoya disease in Japan: A population-based descriptive study.J Stroke Cerebrovasc Dis. 2024 Aug;33(8):107770. doi: 10.1016/j.jstrokecerebrovasdis.2024.107770. Epub 2024 May 18. J Stroke Cerebrovasc Dis. 2024. PMID: 38768667
-
Prevalence of autoimmune disease in moyamoya disease patients in Western Chinese population.J Neurol Sci. 2015 Apr 15;351(1-2):184-186. doi: 10.1016/j.jns.2015.02.037. Epub 2015 Feb 26. J Neurol Sci. 2015. PMID: 25743224
-
High prevalence of pro-thrombotic conditions in adult patients with moyamoya disease and moyamoya syndrome: a single center study.Acta Neurochir (Wien). 2020 Aug;162(8):1853-1859. doi: 10.1007/s00701-020-04420-8. Epub 2020 May 28. Acta Neurochir (Wien). 2020. PMID: 32462312
-
Moyamoya Disease.Front Neurol Neurosci. 2016;40:204-220. doi: 10.1159/000448314. Epub 2016 Dec 2. Front Neurol Neurosci. 2016. PMID: 27960175 Review.
Cited by
-
Moyamoya Disease: Advances in Diagnosis, Treatment, and Surgical Interventions.Cureus. 2024 May 7;16(5):e59826. doi: 10.7759/cureus.59826. eCollection 2024 May. Cureus. 2024. PMID: 38846195 Free PMC article. Review.
-
ReDisX, a machine learning approach, rationalizes rheumatoid arthritis and coronary artery disease patients uniquely upon identifying subpopulation differentiation markers from their genomic data.Front Med (Lausanne). 2022 Aug 22;9:931860. doi: 10.3389/fmed.2022.931860. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36072953 Free PMC article.
-
Coronary Artery Disease in a Young Adult With Unilateral Moyamoya Disease.J Soc Cardiovasc Angiogr Interv. 2022 Sep 24;1(6):100459. doi: 10.1016/j.jscai.2022.100459. eCollection 2022 Nov-Dec. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132340 Free PMC article. No abstract available.
-
Cephalic/cardiac neural crest cell and moyamoya disease.Neuroradiol J. 2021 Dec;34(6):529-533. doi: 10.1177/19714009211021780. Epub 2021 Jun 2. Neuroradiol J. 2021. PMID: 34078151 Free PMC article. Review.
References
-
- Ahn YK, Jeong MH, Bom HS, Park JC, Kim JK, Chung DJ, Chung MY, Cho JG, Kang JC (1999) Myocardial infarction with moyamoya disease and pituitary gigantism in a young female patient. Jpn Circ J 63:644–648. https://doi.org/10.1253/jcj.63.644 - DOI - PubMed
-
- Akasaki T, Kagiyama S, Omae T, Ohya Y, Ibayashi S, Abe I, Fujishima M (1998) Asymptomatic moyamoya disease associated with coronary and renal artery stenoses--a case report. Jpn Circ J 62:136–138. https://doi.org/10.1253/jcj.62.136 - DOI - PubMed
-
- Arima Y, Miyagawa-Tomita S, Maeda K, Asai R, Seya D, Minoux M, Rijli FM, Nishiyama K, Kim KS, Uchijima Y, Ogawa H, Kurihara Y, Kurihara H (2012) Preotic neural crest cells contribute to coronary artery smooth muscle involving endothelin signalling. Nat Commun 3:1267. https://doi.org/10.1038/ncomms2258 - DOI - PubMed
-
- Babaoglu K, Demir T, Saltik L, Kutlug S, Islak C (2007) Moyamoya disease and aortic coarctation in a patient with common brachiocephalic trunk. Anadolu Kardiyol Derg 7:85–87 - PubMed
-
- Baltaxe HA, Bloch S, Mooring PK (1982) Coarctation of the thoracic aorta associated with cerebral arterial occlusive disease. AJR Am J Roentgenol 139:1226–1229. https://doi.org/10.2214/ajr.139.6.1226 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous